Poster presented by Melissa McConechy of British Columbia Cancer Agency at the American Association of Cancer Research 2014: Circulating tumor DNA: FOXL2 402 – > G mutation can be identified in plasma from adult granulosa cell tumor patients with recurrent disease
Top cancer researchers to showcase performance data at AACR Annual Meeting BILLERICA, Mass and SAN DIEGO — April 7, 2014 — RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetics, today announced the availability of its ThunderBolts™ Canc
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.